APA (7th ed.) Citation

Stringer, E. M., Vladutiu, C. J., Batra, P., Stringer, J. S. A., & Menard, M. K. (2016). Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps. Obstetrics & Gynecology, 128(6), 1397. https://doi.org/10.1097/AOG.0000000000001738

Chicago Style (17th ed.) Citation

Stringer, Elizabeth M., Catherine J. Vladutiu, Priya Batra, Jeffrey S. A. Stringer, and M. Kathryn Menard. "Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps." Obstetrics & Gynecology 128, no. 6 (2016): 1397. https://doi.org/10.1097/AOG.0000000000001738.

MLA (9th ed.) Citation

Stringer, Elizabeth M., et al. "Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps." Obstetrics & Gynecology, vol. 128, no. 6, 2016, p. 1397, https://doi.org/10.1097/AOG.0000000000001738.